NASDAQ: SNDLSndl Inc Stock
$1.48+0.03 (+2.07%)
Updated Jun 6, 2023
SNDL Price
$1.48
Fair Value Price
$2.71
Market Cap
$348.09M
52 Week Low
$1.29
52 Week High
$3.97
P/E
-1.44x
P/B
0.35x
P/S
0.58x
PEG
N/A
Dividend Yield
N/A
Revenue
$659.60M
Earnings
-$241.63M
Gross Margin
18.9%
Operating Margin
-32.8%
Profit Margin
-37.2%
Debt to Equity
0.18
Operating Cash Flow
-$21M
Beta
1.26
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SNDL Overview
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNDL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SNDL ($1.48) is undervalued by 45.3% relative to our estimate of its Fair Value price of $2.71 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SNDL ($1.48) is significantly undervalued by 45.3% relative to our estimate of its Fair Value price of $2.71 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SNDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SNDL due diligence checks available for Premium users.
Be the first to know about important SNDL news, forecast changes, insider trades & much more!
SNDL News
Valuation
SNDL fair value
Fair Value of SNDL stock based on Discounted Cash Flow (DCF)
Price
$1.48
Fair Value
$2.71
Undervalued by
45.30%
SNDL ($1.48) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SNDL ($1.48) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SNDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SNDL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.44x
Industry
14.86x
Market
53.54x
SNDL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.35x
Industry
1.79x
SNDL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SNDL's financial health
Profit margin
Revenue
$146.7M
Net Income
-$25.8M
Profit Margin
-17.6%
SNDL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SNDL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$180.1M
Debt to equity
0.18
SNDL's short-term assets ($362.43M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNDL's short-term assets ($362.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNDL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SNDL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$35.4M
Investing
-$4.7M
Financing
-$8.0M
SNDL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SNDL vs Pharmaceutical Stocks
Sndl Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.